NEW YORK (GenomeWeb News) – Protein biomarker technology firm Decision Biomarkers has closed up shop and filed for Chapter 7 bankruptcy.

Decision, based in Waltham, Mass., filed for bankruptcy on Dec. 22 in US Bankruptcy Court in Boston. Decision's website indicates that the company had closed its doors as of Dec. 2, 2009.

"There are several companies interested in the technology and we are hopeful the business will be reconstituted in the near future," Decision said on its website.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.

The New York Times reports that evidence linking trauma in one generation to epigenetic effects that influence subsequent generations may be overstated.

ScienceInsider reports that US National Institutes of Health researchers were told in the fall they could not obtain new human fetal tissue.

In PNAS this week: skin pigmentation evolution among KhoeSan, biomarkers for dengue virus progression, and more.